Market Report Summary
- Market – Insulin Delivery Device Market
- Market Value – US$ 14.09 Bn in 2021
- Market CAGR Value – 7% in 2021
- Market Forecast Year – 2020 to 2030
For Full Information -> Click Here
Read Full Press Release Below
Persistence Market Research Released New Market Report on “Global Market Study on Insulin Delivery Devices – Asia to Witness Highest Growth by 2020” the global insulin delivery devices market is estimated at USD 9,391.1 million in 2014 and is expected to grow at a CAGR of 7% from 2014 to 2020, to reach an estimated value of USD 14,093.3 million in 2020.
The insulin delivery devices market is witnessing a significant growth due to the increasing prevalence of diabetes and rising obese endemic. In addition, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting in the growth of the global insulin delivery devices market.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/2823
Some of the major players operating in the market:
- Abbott Laboratories.
- Novo Nordisk A/S.
- Eli Lilly and Company.
- Medtronic, Inc.
- Sanofi, Becton.
- Dickinson and Company.
- F. Hoffmann-La Roche, Ltd.
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/2823
However, risk and complications associated with the delivery of insulin and high cost of insulin analog hampers the growth of global insulin delivery devices market. As a result, the global insulin delivery devices market is expected to grow a CAGR of 7% during 2014-2020.
North America has the largest market for insulin delivery devices. Increasing prevalence of diabetes and the rising number of overweight and obese people are key drivers of the insulin delivery devices market in the region. In addition, the rising number of elderly people is also supporting the growth of the insulin delivery devices market in the region.
Similarly, the European insulin delivery devices market is mainly driven by the increasing prevalence of diabetes, rising awareness among people about diabetes treatment, technological advancements in insulin delivery devices and increasing aging population.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/2823
In Asia, insulin delivery devices market is growing due to rising aging population and increasing prevalence of diabetes. In addition, several government initiatives are increasing awareness about diabetes treatment which would increase the demand for insulin delivery devices in the region.
In Latin America, construction of manufacturing and research facilities by many companies is driving factor the insulin delivery devices market in the region.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com